Search

everythinglearnresearchcommunity

for

Search:↓

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Men with isolated hypogonadotropic hypogonadism have partial steroid deficiencies, while those with panhypopituitarism have severe deficiencies.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Testosterone increases fluid secretion and aquaporin expression in the vas deferens, which is important for male fertility.

Using finasteride with TIP extends time off period for prostate cancer patients.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

L-threonate may help prevent balding by blocking a key protein.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Trichothiodystrophy can be linked to urologic issues and high calcium in urine.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Genetics may play a significant role in gender dysphoria.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

Dutasteride effectively increases hair density in women with hair loss.

Men with type 2 diabetes often have low testosterone and signs of hypogonadism, especially if they are overweight.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.